Literature DB >> 16513793

Fat aussie--a new Alström syndrome mouse showing a critical role for ALMS1 in obesity, diabetes, and spermatogenesis.

Todor Arsov1, Diego G Silva, Moira K O'Bryan, Amanda Sainsbury, Nicola J Lee, Claire Kennedy, Shehnaaz S M Manji, Keats Nelms, Conan Liu, Carola G Vinuesa, David M de Kretser, Christopher C Goodnow, Nikolai Petrovsky.   

Abstract

Mutations in the human ALMS1 gene are responsible for Alström syndrome, a disorder in which key metabolic and endocrinological features include childhood-onset obesity, metabolic syndrome, and diabetes, as well as infertility. ALMS1 localizes to the basal bodies of cilia and plays a role in intracellular trafficking, but the biological functions of ALMS1 and how these relate to the pathogenesis of obesity, diabetes, and infertility remain unclear. Here we describe a new mouse model of Alström syndrome, fat aussie, caused by a spontaneous mutation in the Alms1 gene. Fat aussie (Alms1 foz/foz) mice are of normal weight when young but, by 120 d of age, they become obese and hyperinsulinemic. Diabetes develops in Alms1 foz/foz mice accompanied by pancreatic islet hyperplasia and islet cysts. Female mice are fertile before the onset of obesity and metabolic syndrome; however, male fat aussie mice are sterile due to a progressive germ cell loss followed by an almost complete block of development at the round-to-elongating spermatid stage of spermatogenesis. In conclusion, Alms1 foz/foz mouse is a new animal model in which to study the pathogenesis of the metabolic and fertility defects of Alström syndrome, including the role of ALMS1 in appetite regulation, pathogenesis of the metabolic syndrome, pancreatic islet physiology, and spermatogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16513793     DOI: 10.1210/me.2005-0494

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  56 in total

Review 1.  Obesity: modern man's fertility nemesis.

Authors:  Stephanie Cabler; Ashok Agarwal; Margot Flint; Stefan S du Plessis
Journal:  Asian J Androl       Date:  2010-06-07       Impact factor: 3.285

Review 2.  Molecular basis of the obesity associated with Bardet-Biedl syndrome.

Authors:  Deng-Fu Guo; Kamal Rahmouni
Journal:  Trends Endocrinol Metab       Date:  2011-04-21       Impact factor: 12.015

Review 3.  Mechanistic insights into Bardet-Biedl syndrome, a model ciliopathy.

Authors:  Norann A Zaghloul; Nicholas Katsanis
Journal:  J Clin Invest       Date:  2009-03-02       Impact factor: 14.808

Review 4.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

Review 5.  The Oak Ridge Polycystic Kidney mouse: modeling ciliopathies of mice and men.

Authors:  Jonathan M Lehman; Edward J Michaud; Trenton R Schoeb; Yesim Aydin-Son; Michael Miller; Bradley K Yoder
Journal:  Dev Dyn       Date:  2008-08       Impact factor: 3.780

Review 6.  Alström syndrome: an ultra-rare monogenic disorder as a model for insulin resistance, type 2 diabetes mellitus and obesity.

Authors:  Francesca Dassie; Francesca Favaretto; Silvia Bettini; Matteo Parolin; Marina Valenti; Felix Reschke; Thomas Danne; Roberto Vettor; Gabriella Milan; Pietro Maffei
Journal:  Endocrine       Date:  2021-02-10       Impact factor: 3.633

7.  The progression from obesity to type 2 diabetes in Alström syndrome.

Authors:  Vera Bettini; Pietro Maffei; Claudio Pagano; Sara Romano; Gabriella Milan; Francesca Favaretto; Jan D Marshall; Richard Paisey; Francesco Scolari; Nella A Greggio; Ilaria Tosetto; Jürgen K Naggert; Nicola Sicolo; Roberto Vettor
Journal:  Pediatr Diabetes       Date:  2011-07-03       Impact factor: 4.866

8.  Linking human diseases to animal models using ontology-based phenotype annotation.

Authors:  Nicole L Washington; Melissa A Haendel; Christopher J Mungall; Michael Ashburner; Monte Westerfield; Suzanna E Lewis
Journal:  PLoS Biol       Date:  2009-11-24       Impact factor: 8.029

9.  Alström syndrome is associated with short stature and reduced GH reserve.

Authors:  S Romano; P Maffei; V Bettini; G Milan; F Favaretto; M Gardiman; J D Marshall; N A Greggio; G B Pozzan; G B Collin; J K Naggert; R Bronson; R Vettor
Journal:  Clin Endocrinol (Oxf)       Date:  2013-03-26       Impact factor: 3.478

10.  Impaired IGF1-GH axis and new therapeutic options in Alström Syndrome patients: a case series.

Authors:  Cristina Maria Mihai; Doina Catrinoiu; Marius Toringhibel; Ramona Mihaela Stoicescu; Negreanu-Pirjol Ticuta; Hancu Anca
Journal:  Cases J       Date:  2009-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.